Idorsia Ltd at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, good afternoon. I'm James Gordon, JPMorgan European Pharma and Biotech analyst. And today, at the JPMorgan Healthcare Conference, it's my pleasure to introduce the Idorsia session with Idorsia's CEO, Jean-Paul Clozel. And today, we're going to have a 20-minute presentation with Jean-Paul, and then we're going to have 20 minutes for questions. And you can immediately start registering your questions. The way you do that is with the Q&A function associated with this presentation that's on the conference website, and then I'll be reading questions from there.
And with that said, I'd like to welcome Jean-Paul to the conference and looking forward to the presentation.
Thank you, James. I suppose that I see my slides or at least some slides. No, they weren't telling me.
Okay. So -- sorry. So thank you very much, James, and thank you for JPMorgan for the invitation. It's nice to be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |